Fatty liver or Non-Alcoholic Fatty Liver Disease (NAFLD) is a term used to describe a condition caused by the build-up of fat in liver cells. Fatty liver is a common condition that affects up to 30% of the population. It is the most common cause of chronic liver disease in developed countries.
Fibroscan is a painless and non-invasive method for evaluating fibrosis or scarring in the liver. Fibroscan measures the stiffness or elasticity of the liver. It uses ultrasound to create waves and measures the speed at which these waves are reflected by the liver. The wave speed is used to determine liver stiffness. Results are presented as a number in kilopascals (kPa). The higher the figure, the stiffer and more scarred the liver has become. Results from Fibroscan should not be confused with fibrosis scores measured on other scoring systems such as liver biopsies. Because it is non-invasive, a Fibroscan can be repeated regularly without risk (unlike a liver biopsy).
Tel: 01 910 8901
Fax: 01 213 5613